Skip to main content
Tessa NewsLink
Paste a health news link, or browse

Several possible studies

Story checked

Researchers test green tea extract in search of preventative treatments for Alzheimer's disease (opens in a new tab)

medicalxpress.com · 2026-09-21

Short answerEvidenceSource

Short answer

Several possible studies

No clear answer.

More than one paper fits the article's details, and none fits well enough to single out. Checking claims against the wrong study would be worse than not checking them at all.

Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.

Share this check

Follow the evidence trail
1
2

NewsLink checks it

Several studies could be the source of this story.

More than one paper fits the article's details, and none fits well enough to single out. Checking claims against the wrong study would be worse than not checking them at all.

Open claim evidence
3

Search result

Several studies could fit.

More than one paper fits the article's details, and none fits well enough to single out. Checking claims against the wrong study would be worse than not checking them at all.

Related research

Research nearby

The papers it could be

Nearby papers when the source is unclear.

and 13 more considered

Then inspect each claim

Evidence layer

Claim by claim

What the story asserts. With no source study, there is nothing to check these against.

Claim 1 of 6Not checkedThree University of Waterloo students are conducting research in Dr. Zoya Leonenko's lab, searching for answers to Alzheimer's disease at the nanoscale.View evidenceHide evidence

Not checked

NewsLink could not identify one source study, so this claim was not compared against a paper.

Claim 2 of 6Not checkedThey are investigating how epigallocatechin gallate (EGCG), a plant antioxidant found in green tea, might help protect against cell damage that leads to Alzheimer's disease.View evidenceHide evidence

Not checked

NewsLink could not identify one source study, so this claim was not compared against a paper.

Claim 3 of 6Not checkedThe team studies model neuronal membranes and how they respond to amyloid beta, including whether EGCG offers protection from amyloid beta oligomers that form pore-like openings allowing ions to pass through.View evidenceHide evidence

Not checked

NewsLink could not identify one source study, so this claim was not compared against a paper.

Claim 4 of 6Not checkedWhen conducting experiments, Baur and Hossfeld observed reduced membrane permeability, suggesting green tea extract could help shield the membrane from damage.View evidenceHide evidence

Not checked

NewsLink could not identify one source study, so this claim was not compared against a paper.

Claim 5 of 6Not checkedUsing SPR, Barichello studied how amyloid beta attaches to the membrane's surface and whether treatment with EGCG can reduce or prevent amyloid buildup on the membrane.View evidenceHide evidence

Not checked

NewsLink could not identify one source study, so this claim was not compared against a paper.

Claim 6 of 6Not checkedThe article says the work could one day contribute to treatments that protect brain health, but more research is needed.View evidenceHide evidence

Not checked

NewsLink could not identify one source study, so this claim was not compared against a paper.

Finally, the search trail

Method layer

No single source study was found.

NewsLink still surfaces nearby research so you can inspect the field instead of a single paper.

Nearby research

No exact source, but these papers are close.

PubMed, Crossref, Europe PMC · 15 candidate papers

Candidate

Faculty Opinions recommendation of Epigallocatechin gallate (EGCG) suppresses beta-amyloid-induced neurotoxicity through inhibiting c-Abl/FE65 nuclear translocation and GSK3 beta activation.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · 2007 · Crossref

Source (opens in a new tab)

And 10 more candidates considered.